Multiple biomarker tissue microarrays: bioinformatics and practical approaches

被引:18
作者
Bentzen, Soren M. [1 ]
Buffa, Francesca M. [2 ]
Wilson, George D. [3 ]
机构
[1] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI 53792 USA
[2] Univ Oxford, John Radcliffe Hosp, Canc Res UK Mol Oncol Labs, Weatherall Inst Mol Med, Oxford OX3 9DU, England
[3] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA
关键词
multiple biomarker; tissue microarrays; bioinformatics;
D O I
10.1007/s10555-008-9145-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Tissue microarrays (TMAs) facilitate high-throughput immunohistochemical analysis of potential predictive and prognostic biomarkers in tumor or normal tissue samples. This technology and the practical issues involved in designing TMAs for translational research are reviewed. A main field of application of TMAs is in the search for predictive and prognostic markers in specific types of cancer. Discussion Standard data analytical approaches are discussed and some of the issues in applying these in practice are described. Conclusions TMAs allow the collection of information-rich datasets on the simultaneous expression of multiple biomarkers. Supervised and unsupervised strategies have been developed for handling datasets where the number of covariates, in this case biomarker expression data, is large in relation to the number of patients in the sample. Some future research pathways are briefly presented together with the recent attempts to improve the reporting quality of biomarker studies.
引用
收藏
页码:481 / 494
页数:14
相关论文
共 89 条
[1]   Profiling and classification tree applied to renal epithelial tumours [J].
Allory, Y. ;
Bazille, C. ;
Vieillefond, A. ;
Molinie, V. ;
Cochand-Priollet, B. ;
Cussenot, O. ;
Callard, P. ;
Sibony, M. .
HISTOPATHOLOGY, 2008, 52 (02) :158-166
[2]   Statistics notes - The cost of dichotomising continuous variables [J].
Altman, DG ;
Royston, P .
BRITISH MEDICAL JOURNAL, 2006, 332 (7549) :1080-1080
[3]   CATEGORIZING CONTINUOUS-VARIABLES [J].
ALTMAN, DG .
BRITISH JOURNAL OF CANCER, 1991, 64 (05) :975-975
[4]   DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS [J].
ALTMAN, DG ;
LAUSEN, B ;
SAUERBREI, W ;
SCHUMACHER, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :829-835
[5]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[6]   Prediction by supervised principal components [J].
Bair, E ;
Hastie, T ;
Paul, D ;
Tibshirani, R .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2006, 101 (473) :119-137
[7]   Radiation and the microenvironment - Tumorigenesis and therapy [J].
Barcellos-Hoff, MH ;
Park, C ;
Wright, EG .
NATURE REVIEWS CANCER, 2005, 5 (11) :867-875
[8]  
BATTIFORA H, 1986, LAB INVEST, V55, P244
[9]   Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial [J].
Bentzen, SM ;
Atasoy, BM ;
Daley, FM ;
Dische, S ;
Richman, PI ;
Saunders, MI ;
Trott, KR ;
Wilson, GD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5560-5567
[10]   A user's guide to evidence-based oncology [J].
Bentzen, SM .
EJC SUPPLEMENTS, 2003, 1 (06) :77-91